Vol. 279, Issue 1, G49-G66, July 2000
Manometric changes during retrograde biliary infusion in
mice
Stephen M.
Wiener1,
Robert F.
Hoyt Jr.2,
John R.
Deleonardis2,
Randall
R.
Clevenger2,
Kenneth R.
Jeffries2,
Kunio
Nagashima3,
Myrna
Mandel4,
Jennie
Owens5,
Michael
Eckhaus5,
Robert
J.
Lutz6, and
Brian
Safer1
1 Molecular Hematology Branch and
2 Laboratory of Animal Medicine and Surgery,
National Heart, Lung, and Blood Institute, National Institutes of
Health, Bethesda 20892; 3 Laboratory of Cell and
Molecular Structure, National Cancer Institute-Frederick Cancer
Research Development Center, Frederick 21270; and
4 Molecular Genetics and
5 Pathology Service, Diagnostic and Surgery
Section, Veterinary Resources Program, National Center for Research
Resources, 6 Bioengineering and Physical Sciences
Program, Office of Research Services, Office of the Director,
National Institutes of Health, Bethesda, Maryland
20892
 |
ABSTRACT |
The manometric,
ultrastructural, radiographic, and physiological consequences of
retrograde biliary infusion were determined in normostatic and
cholestatic mice. Intraluminal biliary pressure changed as a function
of infusion volume, rate, and viscosity. Higher rates of constant
infusion resulted in higher peak intraluminal biliary pressures. The
pattern of pressure changes observed was consistent with biliary
ductular and/or canalicular filling followed by leakage at a threshold
pressure. Retrograde infusion with significant elevations in pressure
led to paracellular leakage of lanthanum chloride, radiopaque dye, and
[14C]sucrose with rapid systemic redistribution
via sinusoidal and subsequent hepatic venous drainage. Chronic
extrahepatic bile duct obstruction resulted in significantly smaller
peak intrabiliary pressures and lower levels of paracellular leakage.
These findings indicate that under both normostatic and cholestatic
conditions elevated intrabiliary volumes/pressures result in an acute
pressure-dependent physical opening of tight junctions, permitting the
movement of infusate from the intrabiliary space into the subepithelial
tissue compartment. Control of intraluminal pressure may potentially permit the selective delivery of macromolecules >18-20
Å in diameter to specific histological compartments.
drug delivery; polarized epithelia; tight junction; cholestasis
 |
INTRODUCTION |
SELECTIVE DELIVERY OF THERAPEUTIC agents to
targeted hepatobiliary tissues and cell types would make possible
safer, more effective treatments by permitting the utilization of
optimal therapeutic dosages combined with a reduction in systemic
toxicity. Potential strategies for improving the tissue specificity of
hepatobiliary treatments include the use of tissue-specific ligands and
the focal administration of therapeutic agents. Although a number of
ligands tropic for the hepatocyte basolateral membrane have been
identified, these agents are not completely tissue specific and can
result in widespread systemic distribution following intravenous administration (17). To date there have been no methods reported for
selectively targeting the basolateral cell membrane of intra- or
extrahepatic cholangiocytes by intravenous administration. Focal
delivery of therapeutic agents to the liver has been primarily directed
for uptake by the hepatocyte basolateral membrane and has included
direct intraparenchymal injection, portal venous infusion, hepatic
arterial infusion (28, 32), and surgical systems for temporarily
isolating the liver from the vasculature (3, 16, 24). These strategies
have shown promise, but problems encountered have included insufficient
first-pass uptake, bleeding complications, an inability to maintain the
infused drug in contact with the targeted tissue for therapeutically
effective periods of time, systemic leakage, or the presence of
extrahepatic metastases.
Only minimal attention has been given to using intrabiliary infusion to
deliver drugs selectively via the apical surface membrane of
cholangiocytes or hepatocytes (31). Recently, retrograde biliary
infusion of gene transfer vectors to the liver and bile ducts has been
examined using adenoviral vectors in mice (14, 19, 35, 36), rats (37),
primates (13, 29), and ex vivo using a cadaveric human liver (33).
Retroviral (5) and liposome-mediated gene transfer (12) have also been
reported following retrograde biliary infusion in rats. However, these prior studies have primarily focused on the process of gene transfer and have not addressed the physiological, anatomic, or acute
histological consequences of vector administration by this route. These
issues will need to be better understood to help develop safe and
effective methods for focal intrabiliary delivery of drugs and vectors. This will include determining 1) the most appropriate method
for intrabiliary infusion (i.e., infusion parameters); 2) the
minimal dwell or contact time that cells should be exposed to vectors or drugs; 3) the optimal intraluminal microenvironments for
effective binding and internalization of particular agents; 4)
the acute histological and pathophysiological effects of intrabiliary
delivery; and 5) whether systemic distribution of infusate
occurs (and if so, by what mechanism). The existence of gene-specific
murine models of human disease makes it particularly attractive to
utilize the mouse for the evaluation of the physiological and
histological consequences of retrograde biliary infusion.
As an initial step in the creation of a murine system for the
comprehensive evaluation of intrabiliary drug and vector delivery, we
report the development and application of a novel system for continuous
cholangiomanometric monitoring during retrograde biliary infusion in
mice. The small size of these animals has previously precluded the
development of techniques for cholangiomanometry. With this system, the
manometric consequences of retrograde biliary administration were
evaluated at different infusion volumes, rates, viscosities, and
temperatures. Intrabiliary pressure changed as a function of infusion
rate, volume, and viscosity. Higher rates of constant infusion resulted
in higher peak intraluminal biliary pressures. The pattern of pressure
changes observed was consistent with ductular and/or canalicular
filling followed by leakage at a threshold pressure. Following
high-pressure retrograde biliary infusion of 5 mM lanthanum chloride, a
molecule that cannot transit across intact tight junctions,
transmission electron microscopy revealed the presence of
electron-dense material in bile canaliculi, interhepatocyte cellular
junctions, and the perisinusoidal space of Disse. Retrograde biliary
infusion of radiopaque contrast material resulted in the
rapid systemic appearance of dye. This leakage from the intrabiliary
space was prevented by temporary obstruction of hepatic venous
drainage, indicating that systemic redistribution following
high-pressure retrograde biliary infusion primarily occurred through
sinusoidal and hepatic venous flow, as opposed to lymphatic flow.
Although retrograde biliary infusion resulted in a similar pattern of
pressure changes in both normostatic and cholestatic animals, there
were significantly smaller initial peak intrabiliary pressures after 4 days of chronic extrahepatic bile duct obstruction, consistent with the
appearance of tight junction disruption in cholestasis.
[14C]sucrose was detected in the systemic
circulation 5 min after high-pressure retrograde biliary infusion.
Since [14C]sucrose cannot pass across an intact
tight junction, its appearance in the systemic circulation following
retrograde biliary infusion provides physiological evidence of tight
junction disruption and biliary leakage.
These findings indicate that, at elevated intrabiliary
volumes/pressures, there is a pressure-dependent physical opening of tight junctions in both normostatic and cholestatic animals, resulting in the leakage of infusate from the intrabiliary space into the subepithelial tissue compartment. This suggests that it may be possible
to selectively deliver large macromolecules (>18-20 Å in diameter, the approximate size exclusion for tight junction passage)
to specific histological tissue compartments through the control of
intraluminal volume and pressure.
 |
MATERIALS AND METHODS |
Animal experiments.
All experiments involving animals were approved by the National Heart,
Lung, and Blood Institute's Animal Care and Use Committee. CD-1 male
mice (20-40 g; Charles River) were used. Anesthesia was induced
and maintained with intraperitoneal 2.5% tribromoethanol (Aldrich
Chemical, Milwaukee, WI).
Cholangiomanometry.
Figure 1 illustrates the experimental
procedures utilized for evaluating the effect of retrograde biliary
infusion on intrabiliary pressure. Following a midline laparotomy, the
gallbladder was manually drained through the cystic duct. A
cholecystotomy catheter (Silastic tubing [0.012-in. ID/0.025-in.
OD]) was secured within the gallbladder lumen with the catheter
tip advanced just proximal to the junction with the cystic duct.
Absorbant cellulose (X0-Med, Jacksonville, FL) was used to prevent bile
leakage into the peritoneum.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic of experimental system for determining effect of retrograde
biliary infusion on intrabiliary pressure. Infusions were administered
through a catheter secured within gallbladder lumen. A second catheter
was inserted through lumen of duodenum and advanced retrograde through
sphincter of Oddi into common bile duct until tip was rostral to
superior pancreatic duct. This catheter was secured in place, thereby
creating an obstruction in common bile duct to anterograde movement of
bile or infusate. Infused material progressively traveled down cystic
duct and then common bile duct until it reached level of pressure
catheter. At this point, infused material began to move in a retrograde
direction. Since biliary tree is a closed ductular system, pressure
recorded from common bile duct pressure transducer accurately reflects
intraluminal pressure throughout entire tree. Manometric readings were
continuously taken every 0.5-2.0 s through common bile duct
catheter using a low-pressure transducer connected to a computer.
|
|
A 23-gauge needle was used to make an opening in the duodenum and to
perform a sphincterotomy on the sphincter of Oddi. A catheter for
recording intrabiliary pressure (PE tubing, 0.011-in. ID/0.024-in. OD)
was inserted through the duodenal opening and advanced retrograde
through the sphincter of Oddi into the common bile duct. The catheter
was advanced so that its tip could be visualized just rostral to the
junction with the superior pancreatic duct. A 6-0 silk tie was
preplaced around the common bile duct and used to secure the catheter
in position. Assuming that the biliary tree is a closed ductular
system, any pressure recorded in the common bile duct accurately
reflected the pressure throughout the entire biliary system.
Intrabiliary pressure was continuously recorded every 0.5-2.0 s
using a low-pressure transducer (Micromed, Louisville, KY) and a
personal computer.
Retrograde biliary infusions were administered using the cholecystotomy
catheter and a microinfusion pump (Harvard). Except as
noted, all infusions were carried out at room temperature (22°C). Infusions traveled in a normograde direction, moving sequentially through the catheter, cystic duct, and common bile duct until reaching
the tip of the pressure catheter. Since the pressure catheter prevented
further anterograde flow, the infusate then reversed direction and
moved retrograde toward the liver.
Electron microscopy.
Animals were infused retrograde with either 5 mM lanthanum chloride
(Sigma) or 0.9% NaCl vehicle. Three infusions of 240-µl volume were
administered per animal at a rate of 2 or 8 µl/s, with a 10-s pause
between infusions. Freshly removed tissue was fixed overnight in 2%
glutaraldehyde in 0.2 M cacodylate buffer. Following standard
processing and embedding, 0.5-µm-thick sections were stained with
uranyl acetate and lead citrate. Sections were then examined using a
Philips 201 Electron Microscope.
Experimental system for evaluating the effect of infusion viscosity
and temperature on intrabiliary pressure.
Solutions of different viscosity were prepared by diluting radiopaque
contrast dye with 0.9% NaCl in the following dye-to-saline ratios:
undiluted dye, 9:1, 3:1, 1:1, 1:3, and saline without dye. The biliary
infusion system was modified to deliver ~37°C infusions. The
infusion catheter was preplaced within the lumen of
-in.
silicone tubing that was continuously perfused with 39°C water.
Solutions were preheated to 39°C and drawn up immediately before
use. We found that the time required for securing the catheter within
the gallbladder lumen resulted in an ~2°C decline in temperature
as measured at the catheter tip.
Viscosity measurements.
Fluid viscosity was determined using an Ostwald capillary viscometer at
22 and 37°C.
Retrograde biliary infusion of radiopaque dye.
A Silastic catheter was placed in the gallbladder as described in
Cholangiomanometry. Straight (1 mm × 3 mm)
or curved (1 mm × 5 mm) Kleinert-Kutz microvascular clips
(Pilling-Weck, Research Triangle, NC) were then placed rostral to the
junction of the superior pancreatic duct with the common bile duct.
Infusions were administered as noted, and the microvascular clip
occlusion caused the infusion to move retrograde. At the end of the
administration period (infusion plus dwell time), the clip was removed
and a preplaced 6-0 silk tie was used to close the gallbladder opening as the cholecystotomy catheter was withdrawn.
Inferior vena cava occlusion.
To evaluate the impact of hepatic venous drainage on the distribution
of radiopaque dye following retrograde biliary infusion, the suprahepatic inferior vena cava was temporarily occluded for 5 or
10 min. The liver was gently retracted caudally, and the falciform
ligament was identified and divided down to the ventral surface of the
vena cava. A curved microvascular clip was used to occlude the vena
cava at a level just cephalad to the liver and caudal to the postcaval
foramen of the diaphragm.
Digital fluoroscopy.
Digital fluoroscopic studies were performed with the
radiopaque contrast dye Renograffin-76 (66% diatrizoate
meglumine and 10% diatrizoate sodium; Solvay Animal Health, Mendota
Heights, MN) and an OEC Series 9400 X-ray imaging system (OEC
Diasonics, Salt Lake City, UT).
Mechanical model of biliary infusion system.
An "elastic," "leaky" biliary system was simulated using a
6-in. length of
-in. diameter silicone tubing that had a
1-in. longitudinal slit cut into it with a scalpel. The proximal end of
the silicone tube was joined to a "T" line. One side of the T was
connected to a Statham pressure transducer and the other end to a
Harvard infusion pump. The distal end of the silicone had a two-way
stopcock valve attached, which was used to either seal the end of the
tube or to vent it when necessary.
Chronic cholestasis experiments.
Following the induction of anesthesia, a midline laparotomy was made
and the common bile duct was visualized. A 6-0 silk tie was
used to occlude the common bile duct rostral to the junction with the
pancreatic ducts. The abdominal incision was closed in two layers with
6-0 silk. Four days later, the animals were reanesthetized and
underwent a repeat laparotomy. A microvascular clip was placed above
the level of the common bile duct occlusion, and a catheter was secured
within the common bile duct. The microvascular clip was then removed,
and baseline intrabiliary pressure was determined. A gallbladder
catheter was then secured in position, and animals received retrograde
biliary infusion as described in Cholangiomanometry.
Measurement of tight junction permeability.
Following a midline laparotomy, both ureters were identified and
occluded with microvascular clips. A catheter was placed within the
gallbladder lumen, and the common bile duct was occluded using a
microvascular clip placed above the junction of the common bile duct
with the superior pancreatic duct. Retrograde biliary infusions
(22°C) of 0.9% NaCl or 2 µCi of
[14C]sucrose (Amersham Pharmacia Biotech,
Piscataway, NJ) diluted in 0.9% NaCl were then administered using a
range of volumes and rates of infusion. Five minutes after the
completion of the infusion, a midsternal incision was rapidly made and
blood was obtained by intracardiac puncture using a 27-gauge needle and
a syringe. Blood was immediately added to a 1.5-ml microcentrifuge tube
containing 10 units of sodium heparin (Elkins-Sinn, Cherry Hill, NJ)
and centrifuged at 4,000 rpm for 5 min. Two hundred microliters of plasma were removed and added to a glass vial containing 15 ml of
scintillation solution (National Diagnostics, Atlanta, GA). Radioactive
counts (cpm) were determined in a scintillation counter (Beckman).
Statistical treatment of results.
Data are presented as means ± SE. Actual volumes administered are
shown. Mean pressure curves were generated by taking the mean pressure
at a specific infusion time point or volume for those animals
administered an infusion at that respective rate and volume. Pressure
changes were determined relative to the preinfusion pressure for each
animal. One-way ANOVA was utilized for comparisons between groups.
Repeated-measures ANOVA was performed when a group of animals received
multiple infusions at the same rate and volume. Post hoc group and
treatment comparisons were performed using a Bonferroni t-test
or a Student-Newman-Keuls test. Linear regression was carried out using
the method of least squares. The relationship between viscosity and
pressure was evaluated by determining the Pearson product-moment
correlation coefficient. Comparison between regression lines was
performed using an overall test for coincidence. P values
<0.05 were considered statistically significant.
 |
RESULTS |
Retrograde biliary infusion leads to intraluminal pressure changes
that are dependent on infusion rate and volume.
Baseline measurements of intrabiliary pressure were continuously
recorded for 25 min during common bile duct occlusion with no
retrograde biliary infusion. Since bile was still being formed, the
intrabiliary pressure gradually rose from a baseline of 0.8 ± 0.2 mmHg (n = 5), reaching a mean pressure of 10.0 ±1.4 mmHg by
10 min (Fig. 2). This pressure remained
fairly constant for at least 25 min, when recording was discontinued.
The small-amplitude episodic fluctuations in intrabiliary pressure may
be indicative of intrabiliary contraction. In several animals, baseline
pressures were recorded for an additional 35-50 min. These
pressures did not markedly differ from those recorded at 25 min (data
not shown).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of common bile duct occlusion on intrabiliary pressure. With use
of system shown in Fig. 1, baseline intrabiliary pressures were
recorded during common duct occlusion. Intrabiliary pressures were
monitored for up to 75 min after occlusion in some animals and were not
different from pressures recorded at 25 min. A: typical
manometric tracing from a single animal. Inset is an enlarged
tracing of an ~9-min period of continuous intrabiliary recording and
reveals the presence of pulsatile waves of contraction. These pressure
waves are consistent with contractile elements participating in
movement of bile in an anterograde direction toward sphincter of Oddi.
B: mean control tracing from a group of 5 mice during common
bile duct occlusion and no retrograde biliary infusion.
|
|
Retrograde biliary infusions at various constant infusion rates
resulted in a characteristic pattern of pressure changes: a progressive
rise in intraluminal pressure until a peak pressure was reached, a
slight decline in pressure, and then a plateau pressure that was
sustained until the infusion was completed. Once the infusion was
stopped, pressure immediately underwent a rapid decline toward the
preinfusion level (Fig. 3A). Figure 3B shows the intrabiliary pressure changes as a function of
time for several infusion rates. The data can also be viewed as the intraluminal pressure changes plotted against volume infused at each
infusion rate instead of against time. These curves are shown in Fig.
3C. Pressure changes were dependent on the infusion rate and
volume. In Fig. 3, panels B and C both indicate
that greater peak pressures were achieved with faster infusion rates.
The pressure rose more rapidly with time at the higher infusion rates
(Fig. 3B), which might be expected with infusions into a
confined space, such as the biliary tree. However, as shown in Fig.
3C, the initial slope of the pressure-volume curve during the
filling phase of the infusion tended to also vary with infusion rate,
being lower at the faster infusion rates (compare the initial slopes of
the 0.066, 0.66, and 2.0 µl/s infusion curves).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 3.
Temporal pattern of pressure changes during retrograde biliary
infusion. Following occlusion of common bile duct, intrabiliary
pressures were recorded while infusing 0.9% NaCl through gallbladder
catheter. This resulted in retrograde biliary delivery of infusate
along with a distinct pattern of changes in intrabiliary pressure.
Pressures were recorded every 0.5-2.0 s using method shown in Fig.
1. A: typical pressure tracing from a single mouse (240 µl
administered at 2 µl/s). Five phases are evident as a result of
retrograde biliary infusion: phase 1 (segment PQ), progressive
rise in intraluminal pressure; phase 2 (Q), peak pressure;
phase 3 (QR), decline in pressure; phase 4 (RS),
sustained, plateau pressure; and, immediately after the infusion is
discontinued, phase 5 (ST), rapid decline in pressure.
B: changes in mean intrabiliary pressure as a function of time
at different infusion rates and volumes. Mean pressure curves for each
infusion volume and rate were generated by taking mean pressure at each
time point. Intrabiliary pressure changes during retrograde
biliary infusion were dependent on both volume and rate of infusion
used. C: changes in intrabiliary pressure as a function of
infusion volume. Data shown in B are presented as mean change
in biliary pressure (mmHg) from preinfusion pressure as a function of
volume infused (µl).
|
|
Figure 4A is a histogram showing
the peak pressure and end of infusion pressure at different infusion
volumes and rates. Peak pressures were significantly different between
the no-infusion group (n = 5) and those animals that received
infusions of 80 µl at 0.66 µl/s (n = 4), 2.66 µl/s
(n = 6), and 5.33 µl/s (n = 5). Volumes of 240 µl
infused at 2 µl/s (n = 4), 8 µl/s (n = 5), and 16 µl/s (n = 4) also resulted in peak pressures significantly different from control (P < 0.05). The 80 µl, 0.066 µl/s
infusion (n = 5) resulted in a peak intrabiliary pressure of
14.5 ± 0.9 mmHg, and this was not significantly different from the
no-infusion group (11.5 ± 1.5 mmHg) but was significantly different
(P < 0.05) from the other 80 µl infusion groups. Peak
pressures were rate dependent; at a given infusion volume, each
infusion rate evaluated resulted in peak pressures significantly
different (P < 0.05) from those obtained using the other
infusion rates. The maximal peak pressure observed was 43.6 ± 0.6 mmHg (240 µl infused at 16 µl/s).

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of infusion rate and volume on peak intrabiliary pressure and
recovery pressure. A: histogram showing effect of infusion rate
and volume on both maximal (peak) intrabiliary pressure during
retrograde biliary infusion and pressure when infusion was completed
(end pressure). All animals underwent common bile duct occlusion.
Control animals underwent common bile duct occlusion without a
retrograde biliary infusion. * P < 0.05 vs. control. NS,
nonsignificant difference. B: effect of infusion rate and
volume on recovery pressure (pressure in period immediately
following completion of a retrograde biliary infusion).
Following completion of an infusion, intrabiliary pressure
rapidly declined toward preinfusion level. Larger-volume,
more rapid rate infusions tended to lead to lower recovery pressures.
|
|
Pressures at the end of infusion were also dependent on both the
infusion rate and volume. Although infusion at 0.66 µl/s resulted in a significant elevation in peak pressure, by the end of the
infusion the pressure was no longer significantly elevated compared with the peak pressure obtained with common bile duct occlusion alone. For all other infusion rates that resulted in significant elevations in peak pressure, end-of-infusion pressure remained significantly elevated compared with the control
pressure. Postinfusion pressures tended to be lower following
larger-volume, more rapid infusions (Fig. 4B).
Repeat infusions result in lower peak intrabiliary pressures.
In some studies, a single animal underwent a sequence of up to four
repeat infusions at the same infusion volume and rate. Pressure was
continuously monitored and each infusion was separated by ~3 min from
the next infusion. Figure 5A shows
a typical time course of three infusions. Figure 5B shows that
repeat infusions resulted in significantly smaller rises in pressure
than were produced by the initial infusion for a particular infusion
rate and volume. This finding was statistically significant except at
the largest volume and fastest rate evaluated (240 µl infused at 16 µl/s). At any given infusion volume and rate, the pressure changes
produced by the second, third, and fourth infusions were not
significantly different from each other, even if the second infusion
had resulted in a pressure change significantly smaller than that
achieved by the first infusion. At faster infusion rates, repeat
infusions tended to lead to postinfusion pressures below the initial
preinfusion pressure (not shown). Figure 5C shows that the
difference between the first and subsequent infusions was apparent
early in the repeat infusion. An initial infusion of 80 µl of 0.9%
NaCl at an infusion rate of 0.66 µl/s (n = 4) produced a rise
in pressure of 16.6 ± 1.3 mmHg after only 16 µl had been infused.
In contrast, infusion of 16 µl during a second infusion at the
identical infusion rate resulted in a significantly smaller pressure
rise (9.6 ± 2.1 mmHg; P < 0.05).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of repeat infusion on intrabiliary pressure. Animals received up
to 4 sequential retrograde biliary infusions. Each infusion was
separated by ~3 min from next infusion. * P < 0.05 vs.
the initial infusion. ** P < 0.05 for comparison among
2nd, 3rd, and 4th infusions. A: typical experimental tracing
from an animal that was administered 3 sequential infusions of 80 µl
over 2 min (0.66 µl/s). Arrows denote onset of each infusion.
B: effect of repeat infusion on maximal pressure change for
different volumes and rates of infusion. C: effect of repeat
infusion on change in intrabiliary pressure as a function of volume
infused. Data are shown for first and second infusions in animals that
were administered 80 µl at 0.66 µl/s; 3rd infusion curve is not
presented because it was virtually identical to 2nd infusion curve.
|
|
Intraluminal pressure changes are determined by infusion viscosity.
To evaluate the impact of infusate viscosity on intraluminal pressure,
animals underwent retrograde biliary administration using a range of
fluid viscosities at different rates and volumes of infusion. As
infusion viscosity was increased, intrabiliary pressure was similarly
elevated. The graph shown in Fig.
6A presents the temporal pattern of
intrabiliary pressure changes at different infusion viscosities. The
effect of viscosity on intrabiliary pressure became more apparent
at later stages of the infusion. Following 11.5 s of infusion (240 µl; 16 µl/s), intrabiliary pressure was significantly greater with
the higher-viscosity infusion (27.1 ± 2.7 mmHg at infusion viscosity
of 0.0070 cm
1 · g · s
vs. 56.8 mmHg ± 8.8 mmHg at infusion viscosity 0.0642 cm
1 · g · s;
P < 0.05). The relationship between fluid viscosity and
intraluminal biliary pressure held over a range of infusion rates and
volumes but was increasingly evident at larger volumes and faster rates
of infusion (Fig. 6B). Figure 6C is a linear regression
analysis of peak intrabiliary pressure as a function of infusion
viscosity at two different infusion temperatures. Intrabiliary pressure
was dependent on infusion viscosity at both 22 and 37°C
(correlation coefficients: 22°C, r = 0.82;
37°C, r = 0.74). Although higher-viscosity infusions tended
to result in greater increases in pressure at 37°C than at
22°C, the linear regression lines shown in Fig. 6C were
not significantly different (P > 0.05). Repeat
infusions with solutions of different viscosities followed the same
pattern as was seen in Fig. 5B with saline infusion, i.e.,
repeat infusions resulted in significantly lower peak pressure changes
than were produced by the initial infusion (data not shown).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of infusion viscosity on intrabiliary pressure. Animals were
administered retrograde biliary infusions using a range of fluid
viscosities. Fluid was administered at both room temperature (22°C)
and 37°C. A: temporal pattern of pressure changes as a
function of infusion viscosity. Mean pressure tracings are shown for
animals that received infusions of 37°C fluid at 240 µl over 15 s. Higher-viscosity infusions led to increasingly elevated intrabiliary
pressures compared with lower-viscosity infusions. Similar patterns
were observed with other rates, volumes, and temperatures. B:
Bar graph showing means ± SE of peak intrabiliary pressures observed
at 37°C as a function of infusion rate and viscosity. Numbers on
bars refer to number of experiments per condition. Peak pressure was
elevated in a viscosity-dependent fashion, with this effect
increasingly evident as infusion rate and volume were increased.
* P < 0.05 compared with 0.0070 cm 1 · g · s
viscosity infusion for that volume and rate of infusion.
** P < 0.05 compared with 0.0366 cm 1 · g · s
viscosity infusion for that volume and rate of infusion. C:
Linear regression analysis of relationship between viscosity and peak
intrabiliary pressure at 2 infusion temperatures (22 and 37°C).
|
|
High-pressure retrograde biliary infusion results in the acute
disruption of interhepatocyte tight junctions.
The pattern of pressure changes observed following retrograde biliary
infusion, in conjunction with the finding that repetitive infusions
lead to significantly lower peak intrabiliary pressures, suggest that
retrograde biliary infusion leads to biliary ductular and/or
canalicular filling followed by leakage at a threshold pressure.
Movement of fluid from the intraluminal space may conceivably occur
either directly across physically opened tight junctions or indirectly
by altered rates of transepithelial transcytosis. However, the rapidity
of the pressure changes observed above suggest that tight junction
disruption is a more likely mechanism. We evaluated the ability of
retrograde biliary infusion to disrupt tight junctions by qualitative
ultrastructural examination of the intrahepatic distribution of
lanthanum chloride, a heavy metal normally impermeant to structurally
intact tight junctions (Figs. 7, 8, and 9). Electron-dense deposits
consistent with the presence of lanthanum chloride were found within
bile ducts but not in their adjacent subepithelial tissue compartments
following retrograde biliary infusion of 720 µl of 5 mM lanthanum
chloride administered at a rate of 2 µl/s or 8 µl/s (Fig.
7). In contrast, electron-dense deposits
were found within biliary canaliculi, interhepatocyte cell spaces, and
the perisinusoidal space of Disse (Fig. 8).
Figure 9 consists of electron micrographs
that reveal the probable overall pathway taken by high-pressure
retrograde biliary infusate: from biliary canaliculi to their adjacent
subepithelial compartments, i.e., through cell junctions, then coursing
in the lateral intercellular spaces before ultimately reaching the
perisinusoidal space of Disse. The presence of lanthanum chloride
within interhepatocyte cell spaces and the perisinusoidal space of
Disse immediately following high-pressure retrograde biliary infusion
are consistent with an acute alteration of tight junction permeability.
It is theoretically possible (but extremely unlikely within the time frame of these experiments) that active transport (including
transcytosis) resulted in the movement of lanthanum chloride from the
intraluminal space to the lateral intercellular space and the space of
Disse. An alteration in tight junction permeability rather than
transcytosis is also supported by the failure to find ultrastructural
evidence of lanthanum chloride particles intracellularly within either hepatocytes or cholangiocytes.

View larger version (195K):
[in this window]
[in a new window]
|
Fig. 7.
Lanthanum chloride remains confined to lumen of intrahepatic bile ducts
following high-pressure retrograde biliary infusion. Transmission
electron microscopy (TEM) was used to look for evidence of tight
junction disruption in intrahepatic bile ducts following high-pressure
retrograde biliary infusion. Animals were administered 5 mM lanthanum
chloride or vehicle by high-pressure retrograde biliary infusion (3 infusions of 240 µl/animal, administered at a rate of 2 or 8 µl/s,
with a 10-s pause between infusions). Immediately following completion
of final infusion, liver was removed and prepared for TEM. Areas with
typical electron-dense deposits consistent with presence of lanthanum
chloride are circled. Lanthanum chloride deposits were detected within
lumen of bile ducts but were not found in immediately adjacent
subepithelial tissue compartments (lamina propria or peribiliary
capillary plexus). Panels A-D are representative
sequentially higher magnifications of a typical intrahepatic bile duct
from experimental animals.
|
|

View larger version (138K):
[in this window]
[in a new window]
|
Fig. 8.
Lanthanum chloride is not confined to lumen of biliary canaliculi
following high-pressure retrograde biliary infusion. Tissue samples
from animals described in Fig. 7 were evaluated for disruption of
canalicular tight junctions. Electron-dense deposits, consistent with
presence of lanthanum chloride, were detected within bile ducts,
biliary canaliculi, interhepatocyte cellular junctions, and
perisinusoidal space of Disse. Since tight junctions are normally
impermeable to lanthanum chloride, presence of electron-dense deposits
within cellular junctions and perisinusoidal space of Disse most likely
occurred by tight junction disruption. Representative images are
presented. A: negative (vehicle) control.
B-E: experimental tissues. Arrows denote
interpreted pathway of paracellular leakage.
|
|

View larger version (145K):
[in this window]
[in a new window]
|
Fig. 9.
Overall pathway of paracellular leakage of lanthanum chloride following
high-pressure retrograde biliary infusion. Electron micrographs are
presented illustrating overall pattern of lanthanum chloride deposition
following high-pressure retrograde biliary administration.
Electron-dense deposits, consistent with lanthanum chloride, can be
seen throughout these areas on micrographs shown.
A-C are experimental tissues. Arrows denote
interpreted pathway of paracellular leakage, i.e., movement from
canalicular lumen across disrupted canalicular tight junctions into
lateral intercellular space and subsequently into perisinusoidal space
of Disse.
|
|
High-pressure retrograde biliary infusion results in the systemic
distribution of radiopaque contrast dye through hepatic
venous drainage.
Since high-pressure retrograde biliary infusion appeared to result in
the transit of retrograde biliary infusate from canaliculi through the
lateral intercellular space to the space of Disse, we sought to
determine the ultimate redistribution pathway taken following
retrograde biliary infusion. In some animals radiopaque contrast dye
(infusion temperature 22°C, fluid viscosity 0.0285 or 0.1216 cm
1 · g · s)
was rapidly infused retrograde (80 µl or 240 µl, 2-16 µl/s),
and simultaneous digital fluoroscopy was utilized to determine if, and
when, dye entered the systemic circulation. Digital images captured at
30 frames/s revealed the rapid appearance of dye in the systemic
circulation. Figure 9 shows a typical example of these studies. Dye
appeared to travel up the suprahepatic inferior vena cava (Fig.
10A) before being
seen in the heart (Fig. 10B). The identification of this
structure as the inferior vena cava was confirmed by temporarily
preventing hepatic venous return during an identical experiment.
Temporary obstruction of the suprahepatic inferior vena cava prevented
systemic distribution during and after high-pressure retrograde biliary
infusion (Fig. 10, C and D). Accordingly, although some
degree of lymphatic drainage may possibly have occurred, high-pressure
retrograde biliary infusion of radiopaque dye appears to
have primarily resulted in systemic delivery of infusate via hepatic
venous drainage.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 10.
Effect of suprahepatic inferior vena cava occlusion on systemic
distribution of radiopaque dye delivered by high-pressure retrograde
biliary infusion. Digital fluoroscopy was used to determine whether
high-pressure retrograde biliary infusion would lead to systemic
leakage and, if so, by what route. A and B:
radiopaque contrast material was administered (240 µl,
8 µl/s), and images were recorded 30 times/s. A: fluoroscopic
image showing dye having filled liver and subsequently entering
systemic circulation. IVC, suprahepatic inferior vena cava. B:
masked image showing dye in liver and heart. C and D:
effect of occlusion of suprahepatic inferior vena cava on systemic
distribution of dye. This animal was administered dye under same
high-pressure conditions except that suprahepatic inferior vena cava
was occluded using a microvascular clip before infusion and for 5 min
afterwards. Dye was not seen in systemic circulation until IVC clip was
removed. C: preinfusion masked image. CBD, common bile duct.
D: postinfusion masked image taken 2 min after completion of
infusion. Dye remains confined to liver.
|
|
Simultaneous measurement of intrabiliary pressure during digital
fluoroscopic recording of retrograde biliary infusion revealed that
radiopaque dye appeared in the systemic circulation as the intrabiliary
pressure was rapidly rising and was greatest once the peak pressure was
reached. Figure 11 shows
an example of these studies. At an infusion rate of 8 µl/s (infusion
temperature 22°C, fluid viscosity 0.0285 cm
1 · g · s),
pressure began to rise after 2 s or 16 µl of dye had been infused.
Dye began to be evident in the lungs after 3 s or 24 µl had been
infused. The intensity of dye in the liver continued to increase even
after systemic distribution was first detected. After 5 s (40 µl),
dye became more pronounced in the inferior vena cava. At 6 s (48 µl),
peak pressure was reached and dye was much more evident in the liver,
inferior vena cava, and lungs. Digital subtraction fluoroscopy was
utilized to compare the hepatic distribution of dye following repeat
infusions in the same animal. With each new infusion, the liver
parenchyma was filled earlier and at a lower pressure (data not shown).

View larger version (104K):
[in this window]
[in a new window]
|
Fig. 11.
Relationship between intrabiliary pressure and onset of systemic
leakage of radiopaque dye. To determine when systemic leakage occurred,
animals underwent high-pressure retrograde biliary infusion of
radiopaque contrast dye while simultaneously having intrabiliary
pressure measured, and digital fluoroscopic images were recorded.
Radiopaque dye initially appeared in systemic circulation as
intrabiliary pressure was rapidly rising and was greatest once peak
pressure was reached. Shown are results from infusion of dye at 8 µl/s. Systemic leakage was initially detected after only 24 µl had
been infused (3 s).
|
|
As a model of the physiological events that occur during retrograde
biliary infusion, a mechanical analog of the biliary infusion system
was constructed. Figure 12 shows that the
pressure in this system rises when an infusion is started. The slit in
the tube remains closed initially due to the elastic forces of the
silicone and, to some extent, due to the adhesion of the slit facets to each other. At ~48 mmHg, enough pressure force occurs to open the
slit, as evidenced by the continual leakage of infusate from the tube
slit. At this moment, the pressure falls and achieves a new
steady-state pressure of ~22 mmHg, which is sufficient to maintain
the constant rate of leakage. When the infusion is stopped, the
pressure gradually declines as the fluid continues to slowly leak from
the slit. When the stopcock is opened and the system is vented, the
pressure falls to 0 mmHg. This process can be repeated, but there is a
notable reduction in the threshold slit opening pressure the second
time to ~40 mmHg. The reduced threshold pressure may result from the
initial disruption of the slit's elastic and adhesive forces,
rendering it easier to open on subsequent infusions.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 12.
Mechanical model of retrograde biliary infusion. Intraluminal pressure
was monitored during constant-rate infusion into a closed silicone tube
with a closed, longitudinal slit. This provided a mechanical analog of
retrograde biliary infusion with features of both elasticity and
leakiness. Shown are pressure recordings from a typical experiment.
Manometric recording during constant infusion rates resulted in
patterns of pressure changes very similar to those obtained with
retrograde biliary infusion in vivo (compare initial infusion with Fig.
3A and repeat infusion with Fig. 5). Peak intraluminal pressure
and leakage of infusate were dependent on both infusion volume and rate
(data not shown).
|
|
Chronic cholestasis reduces the peak intrabiliary pressure response
to retrograde biliary infusion.
To determine the effect of chronic cholestasis on the dynamic response
of the biliary system to retrograde biliary infusion, a group of
animals underwent 4 days of chronic extrahepatic bile duct obstruction.
Biliary manometry was then performed using a range of retrograde
biliary volumes and rates of infusion (Fig. 13). Intrabiliary pressure after 4 days
of cholestasis was compared with the values previously shown in Fig. 2
(t = 0 min for unobstructed and t = 10 min
for 10 min of common bile duct obstruction). After 4 days of chronic
extrahepatic bile duct obstruction, baseline (preinfusion) intrabiliary
pressure remained significantly elevated [normostasis baseline = 0.8 ± 0.2 mmHg (n = 5); 4 days of cholestasis, 8.2 ± 1.0 mmHg (n = 10); P < 0.05]. The preinfusion
intrabiliary pressure after 4 days of cholestasis was not significantly
different from the pressure level after only 10 min of biliary tree
obstruction [10 min of cholestasis = 10.0 ± 1.4 mmHg (n = 5); 48 h of cholestasis = 8.2 ± 1.0 mmHg (n = 10);
P > 0.05].

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 13.
Manometric changes during retrograde biliary infusion in chronically
cholestatic mice. A: pattern of pressure changes observed in
chronically cholestatic animals following retrograde biliary infusion.
Data are presented as change in pressure (mmHg) from preinfusion value
as a function of infusion time(s). Cholestatic animals had patterns of
pressure changes similar to those seen in normostatic animals following
retrograde biliary infusion (for comparison with normostatic animals,
see Fig. 3), i.e., 5 phases consisting of 1) a progressive rise
in intraluminal pressure; 2) a peak pressure; 3) a
decline in pressure; 4) a sustained, plateau pressure; and,
immediately after infusion is discontinued, 5) a rapid decline
in pressure. B: effect of chronic cholestasis on maximal change
in pressure during retrograde biliary infusion. Both normostatic (N)
and chronically cholestatic (C) animals (4 days of chronic extrahepatic
bile duct obstruction) were evaluated for effect of repeat retrograde
biliary infusion on intraluminal pressure. Numbers on bars represent
number of experiments per condition. Retrograde biliary infusion
resulted in significantly smaller rises in intrabiliary pressure in
cholestatic animals than in normostatic animals. In both normostatic
and cholestatic animals, repeat infusions tended to result in smaller
changes in pressure than achieved with an initial infusion. However,
this effect became significant in cholestatic animals only at higher
rates and volumes of infusion. * P < 0.05 for comparison
between first and subsequent infusions at a particular infusion rate.
** P < 0.05 for comparison between normostatic and
cholestatic animals for an identical infusion condition. NS,
nonsignificant difference.
|
|
Figure 13A shows that cholestatic animals had a similar pattern
of pressure changes to those seen in Fig. 3 for normostatic animals,
namely a progressive rise in intraluminal pressure until a peak
pressure was reached, a slight decline in pressure, and then a plateau
pressure that was sustained until the infusion was completed. Once the
infusion was stopped, pressure immediately underwent a rapid decline
toward the preinfusion value. As in normostatic animals, pressure
changes in cholestatic animals were also dependent on the infusion rate
and volume. Greater peak pressures were achieved with faster infusion
rates, and the pressure rose more rapidly with time at the higher
infusion rates. Peak pressures were similarly infusion rate dependent;
at a given infusion volume, increasing the infusion rate resulted in
peak pressures significantly different (P < 0.05) from those
obtained using slower infusion rates (Fig. 13B). Pressures at
the end of infusion were also dependent on both the infusion rate and
volume. Unlike normostatic animals, postinfusion pressures did not tend
to be lower following larger-volume, more rapid infusions.
In both normostatic and cholestatic animals, repeat retrograde biliary
infusion tended to result in lower peak intrabiliary pressures than the
initial infusion (Fig. 13C). However, this effect was more
pronounced with the normostatic animals because they tended to have
significantly greater maximal changes in intrabiliary pressure after an
initial infusion than cholestatic animals for a given infusion rate and
volume. At larger volumes and more rapid rates of infusion, the
differences between normostatic and cholestatic animals became less pronounced.
Retrograde biliary infusion results in tight junction disruption in
both normostatic and cholestatic animals.
To determine the effect of retrograde biliary infusion on tight
junction permeability under both normostatic and cholestatic conditions, [14C]sucrose was infused retrograde
using a range of infusion rates and volumes in naive mice and after 4 days of chronic extrahepatic bile duct obstruction. Plasma samples were
obtained 5 min later by intracardiac puncture. Since physically intact
tight junctions are impermeant to sucrose, the appearance of
[14C]sucrose in the systemic circulation under
these experimental conditions would signify that tight junction
disruption had occurred. Figure 14 shows
the results from this experiment. In normostatic animals, systemic
leakage of [14C]sucrose at 5 min after infusion
was detected at approximately equivalent levels across a range of
infusion rates and volumes. In cholestatic animals, the amount of
leakage tended to be lower than for normostatic animals at a given
infusion volume and rate. In cholestatic animals, increasing infusion
volume or infusion duration tended to lead to greater amounts of
paracellular leakage.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 14.
Effect of retrograde biliary infusion on tight junction permeability in
normostatic and chronically cholestatic animals. Tight junction
permeability was assessed by retrograde biliary infusion of
[14C]sucrose at a range of volumes and rates of
infusion in both normostatic and chronically cholestatic animals.
Heparinized blood samples were obtained by cardiac puncture 5 min
later, and 200-µl aliquots of plasma were assayed in a scintillation
counter for 14C content. Since tight junctions are normally
impermeable to sucrose, presence of
[14C]sucrose in systemic circulation following
retrograde biliary infusion suggests that tight junction disruption
occurred in both normostatic and cholestatic animals. However, in
cholestatic animals retrograde biliary infusion tended to result in
lower levels of paracellular leakage of
[14C]sucrose than in normostatic animals under
identical infusion conditions.
|
|
 |
DISCUSSION |
These experiments indicate that retrograde biliary infusion beyond a
critical filling volume/pressure results in the acute opening of tight
junctions in both normostatic and chronically cholestatic mice, leading
to the progressive movement of infusate from the canalicular lumen to
the lateral intercellular space and then into the perisinusoidal space
of Disse. Redistribution of infusate from the space of Disse appears to
occur via hepatic sinusoidal and subsequent hepatic venous drainage
rather than lymphatic drainage. Intrabiliary pressure changes were
dependent on the infusion volume, rate, and viscosity. Digital
fluoroscopic evaluation (Fig. 11) revealed that the murine biliary tree
was filled to the point of systemic leakage after ~24-48
µl of infusate had been administered at 8 µl/s. Delivery at
other rates can result in filling at different volumes (see Fig. 3).
During constant-rate retrograde biliary infusion in mice, a consistent
pattern of pressure changes occurs as shown in Fig. 3. This consists of
a gradual pressure rise,
a threshold peak pressure, and then a variable decline to a steady-state
level. Once the infusion is discontinued, intrabiliary pressure rapidly declines toward the preinfusion pressure. The amplitude and chronology of this pattern may be altered by varying the infusion rate, volume, or
viscosity. Repeat infusions result in peak intraluminal pressure changes significantly lower than are produced by an initial infusion using the same volume and rate of infusion.
Retrograde biliary infusion increases the total fluid volume within a
confined luminal space (the biliary tree) and will, therefore, raise
intrabiliary pressure. The pattern and degree of pressure changes will
be determined by whether biliary ductular structures can adapt to
increased wall tension and/or have leakage sites through which fluid
may potentially exit at elevated intraluminal pressures. Contractile
elements are found around bile ducts and canaliculi, and their rhythmic
activity may play an important role in normal bile flow (21, 34). Total
canalicular and ductular diameter can increase in response to chronic
extrahepatic bile duct obstruction (11, 27). It is, therefore, possible
that these elements may function in some ways analogous to the role of
smooth muscle cells in vascular capacitance vessels, i.e., capable of
slow adaptation to increased intraluminal volume. However, whether the
caliber (i.e., diameter and tone) of biliary structures can
acutely change in response to intraluminal stimuli is less clear.
Loss of fluid from the intraluminal space in response to elevated pressure could conceivably occur either directly by
causing paracellular movement across disrupted tight junctions or
indirectly by enhancing rates of fluid internalization and movement via
apical membrane endocytosis, macrocytosis, or epithelial transcytosis.
Figure 3 indicates that biliary structures do have some component of
acute capacitance because incremental increases in the volume of
infusate initially resulted in gradual changes in intrabiliary pressure. A rigid or saturated ductular system would have demonstrated a much larger pressure change in response to the addition of only small
increments of fluid volume. It is unclear whether this component of
capacitance represents the filling of void space in flaccid tubular
structures or the distension (or relaxation) of viscoelastic elements
in response to the increase in intrabiliary volume. That the initial
slopes of the curves shown in Fig. 3C vary with infusion rate
suggests that biliary ductular structures may also have some component
of acute distensibility that is in the nature of a viscoelastic tube.
Viscoelasticity of bile ducts and canaliculi is histologically plausible since an extracellular matrix is present in the space of
Disse, deep to the basement membrane of biliary epithelial cells, as
well as throughout the hepatic parenchyma (26). However, a more
appropriate future analysis of distensibility could be obtained with
steady-state (i.e., constant-pressure) conditions. This would also make
it possible to more fully evaluate whether biliary capacitance can
acutely change in response to intrabiliary infusion (by, for example,
relaxation of contractile elements and/or changes in biliary ductular diameter).
The mechanical model shown in Fig. 12, although only a simple
representation of a complex anatomic system, does provide a
didactic tool to investigate potential explanations for the
pressure curves in Figs. 3, 4, and 5. There are notable similarities
between the mechanical model and the actual biliary pressure curves
obtained from in vivo experiments. The elasticity of the
silicone tube may mimic the distensibility of the bile ducts, ductules,
and canaliculi. The "leaky slit" may be analogous to disruption
of tight junctions within the hepatobiliary tree. Once disrupted, the
leakage of infusate can occur into the space outside the tube (space of
Disse and/or subepithelial space), allowing the pressure to fall to a
lower steady-state value necessary to maintain that rate of leakage.
With subsequent infusions, the threshold pressure for leakage is
lowered since the slit (tight junction) has been weakened by previous
disruption. Very large-volume, rapid-rate repeat infusions can mask
this defect, resulting in peak intraluminal pressures similar to those
seen with the initial infusion.
Tight junctions in the hepatobiliary tree maintain cellular polarity by
keeping the luminal space physically (and, therefore, functionally)
separated from the subepithelial tissue compartment (2,
22). Biliary canalicular (2) and probably ductular (30)
tight junctions play a critical role in maintaining selective biliary
tree permeability to different solutes. In rats, retrograde biliary
administration has been reported as leading to increased absorption of
infusate as a function of infusate volume (6, 20). This suggests that
an acute increase in biliary permeability occurred, consistent with the
hypothesis that increasing intrabiliary pressure may result in a
structural change in canalicular and/or ductular tight junctions.
Experimental studies of chronic extrahepatic cholestasis also support a
connection between elevated intrabiliary pressure and biliary tree
leakiness. A preliminary study in ethinyl estradiol-induced cholestatic
rats found that retrograde biliary infusion resulted in evidence of
paracellular leakage (4). Chronic extrahepatic biliary obstruction
results in structural alterations in canalicular tight junctions (1,
7-10, 15, 18, 23, 25) and accumulation in the space of Disse of ZO-1
and occludin proteins, structural components of these junctions (1, 8,
9). These changes appear to correlate with increased functional
leakiness across the canalicular tight junction (7, 8, 9, 18).
Canalicular changes are detectable within 48 h of the onset of
obstruction (23). However, it is unknown whether chronic extrahepatic
obstruction directly effects canalicular tight junctions through
elevations in intrabiliary pressure or through some other mechanism.
Our data support the hypothesis that at sufficiently high intraluminal pressures, tight junctions may undergo acute, mechanical alteration, acting as a pressure release valve that removes excess
intrabiliary volume from the luminal compartment. Tight
junctions vary in terms of their structure and functional leakiness
(22), and we speculate that they may also have different pressure
thresholds for physical opening.
In cholestatic animals, retrograde biliary infusion resulted in
significantly lower peak intrabiliary pressures during a first infusion
than were observed under first infusion conditions in normostatic
animals. This suggests that chronic extrahepatic bile duct obstruction
resulted in some degree of tight junction disruption independent of any
induced by retrograde biliary infusion. However, cholestatic animals
also tended to have smaller amounts of
[14C]sucrose in the bloodstream 5 min after
retrograde biliary infusion than did normostatic animals. One possible
explanation for this apparently contradictory finding is that peak
intrabiliary pressure may directly affect the diameter to which tight
junctions are opened and/or the driving force for paracellular movement
and thereby determine the amount of paracellular leakage of molecules of a particular diameter. If this possibility is correct, then in the
present experiments the tight junction disruption known to be
caused by cholestasis was sufficient for there to be some amount of
leakage of molecules smaller than sucrose (e.g., water) during a
retrograde biliary infusion. This fluid leakage would have thereby
minimized the extent of the peak intrabiliary pressure rise achieved
during a retrograde biliary infusion. This smaller peak intrabiliary
pressure in turn could have diminished the number of tight junctions
that were acutely widened to the degree that molecules of the diameter
of sucrose would acutely pass through or alternatively may have reduced
the driving force (pressure gradient) driving the paracellular movement
of sucrose across disrupted tight junctions. Future experiments using a
range of different diameter molecules and infusion pressures will be
necessary to more precisely determine the correlation between the
absolute level of intrabiliary pressure, the degree of tight junction
disruption, and the amount of paracellular leakage.
Obstruction of hepatic venous return increases hepatic sinusoidal
hydrostatic pressure, thereby increasing the rate and volume of
lymphatic drainage. Accordingly, if retrograde biliary infusate enters
the sinusoidal space, it would be predicted that obstruction of hepatic
venous return would lead to increased lymphatic drainage of any leaked
material and, therefore, continued systemic redistribution. However,
Fig. 10 indicates that hepatic venous obstruction prevented the
appearance in the systemic circulation of radiopaque contrast material
administered by high-pressure retrograde biliary infusion. This does
not rule out some component of lymphatic drainage but does imply that
under these particular experimental conditions retrograde biliary
infusion leads to systemic distribution of leaked infusate primarily by
venous rather than lymphatic drainage. These findings also suggest that
hepatic venous obstruction may have prevented or reduced movement of
infusate across disrupted tight junctions. Increased sinusoidal
pressure may have been sufficient to oppose and overcome the pressure
force driving the movement of infusate through this pathway.
In conjunction, the lanthanum chloride and
[14C]sucrose studies indicate that
high-pressure retrograde biliary infusion is associated with an acute
disruption of interhepatocyte canalicular tight junctions and the
subsequent movement of molecules in the size range of 7,000-11,000
Da into the lateral intercellular space and then into the
perisinusoidal space of Disse. Since the transmission electron
micrograph studies were done on a qualitative rather than a
quantitative basis, it is also conceivable that at sufficiently high
intraluminal pressures, tight junctions between adjacent epithelial
cells in larger intra- or extrahepatic bile ducts may be similarly
disrupted. This could result in the entry of infusate into venous
and/or lymphatic capillaries located within the lamina propria, the
subepithelial tissue compartment of these structures. Such venous
drainage would ultimately be distributed in a vascular pattern (i.e.,
sinusoidal distribution) within the liver.
In summary, we have developed a novel system for cholangiomanometry in
mice and have used this to evaluate the acute physiological consequences of retrograde biliary infusion at different infusion rates, volumes, viscosities, and temperatures. Our data suggest that
under both normostatic and cholestatic conditions elevated intrabiliary
volumes/pressures result in a physical opening of tight junctions,
leading to the leakage of infusate from the intrabiliary space into the
subepithelial tissue compartment. Control of intrabiliary infusion
pressure may, therefore, potentially provide a novel method for the
selective delivery of therapeutic agents to either the intrabiliary or
subepithelial tissue compartment(s). These results may also be
applicable to other luminal structures lined by polarized epithelial
cells. Further experimentation will be required (using macromolecules
having a range of sizes and charges) to more precisely determine the
relationship between different levels of intraluminal pressure and the
acute histological distribution of macromolecules normally excluded by
an intact paracellular barrier.
 |
ACKNOWLEDGEMENTS |
We thank Katherine Anders, Gabrielle Kotler, Melody Lowe, Erin
Stewart, Karen Lipovsky, Kelly Cole, and Brian Van Den Woude for
assistance with viscosity experiments, Howard Bartner for medical
illustrations, and Michael Juhn for help with computer graphics.
 |
FOOTNOTES |
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: S. M. Wiener, Massachusetts General Hospital, Gastrointestinal Unit-GRJ 722, 55 Fruit St., Boston, MA 02114 (E-mail:
SWiener{at}Partners.org).
Received 19 August 1998; accepted in final form 28 December 1999.
 |
REFERENCES |
1.
Anderson, JM,
Glade JL,
Stevenson BR,
Boyer JL,
and
Mooseker MS.
Hepatic immunohistochemical localization of the tight junction protein ZO-1 in rat models of cholestasis.
Am J Pathol
134:
1055-1062,
1989[Abstract].
2.
Anderson, JM,
and
Van Itallie CM.
Tight junctions and the molecular basis for regulation of paracellular permeability.
Am J Physiol Gastrointest Liver Physiol
269:
G467-G475,
1995[Abstract/Free Full Text].
3.
Barker, WC,
Andrich MP,
Alexander HR,
and
Fraker DL.
Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs.
Eur J Nucl Med
22:
1242-1248,
1995[Web of Science][Medline].
4.
Boyer, JL,
LaGarde S,
Ng O-C,
and
Groszman R.
Enhanced biliary regurgitation of 14C-sucrose (14C-S) and Lanthanum (La+++) in ethinyl estradiol (EE) treated rats following retrograde bile duct infusions
a possible mechanism for intrahepatic cholestasis (Abstract).
Hepatology
1:
498,
1981.
5.
Cabrera, JA,
Wilson JM,
and
Raper SE.
Targeted retroviral gene transfer into the rat biliary tract.
Somat Cell Mol Genet
22:
21-29,
1996[Web of Science][Medline].
6.
Dammann, HG,
and
Essen J.
Influence of retrograde volume and shorttime cholestasis on the biliary reabsorption of sulfobromophthalein sodium (BSP) and phenol 3,6 dibromphthalein disulfonate (DBSP) from the rat biliary tree after retrograde biliary injection (RII).
Res Exp Med (Berl)
168:
187-198,
1976[Medline].
7.
De Vos, R,
and
Desmet VJ.
Morphological changes of the junctional complex of the hepatocytes in rat liver after bile duct ligation.
Br J Exp Pathol
59:
220-227,
1978[Web of Science][Medline].
8.
Fallon, MB,
Brecher AR,
Balda MS,
Matter K,
and
Anderson JM.
Altered hepatic localization and expression of occludin after common bile duct ligation.
Am J Physiol Cell Physiol
269:
C1057-C1062,
1995[Abstract/Free Full Text].
9.
Fallon, MB,
Mennone A,
and
Anderson JM.
Altered expression and localization of the tight junction protein ZO-1 after common bile duct ligation.
Am J Physiol Cell Physiol
262:
C1439-C1447,
1992.
10.
Gaudi, E,
Onori P,
Pannarale L,
and
Alvaro D.
Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study.
Gastroenterology
11:
1118-1124,
1996.
11.
Hampton, JC.
Electron microscopic study of extrahepatic biliary obstruction in the mouse.
Lab Invest
10:
502-513,
1961[Web of Science][Medline].
12.
Hayashi, N,
Takehara T,
and
Kamada T.
In vivo transfection of rat liver with hepatitis C virus cDNA using cationic liposome-mediated gene delivery.
Princess Takamatsu Symp
25:
143-149,
1995[Medline].
13.
Hofland, HE,
Nagy D,
Liu JJ,
Spratt K,
Lee YL,
Danos O,
and
Sullivan SM.
In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex.
Pharm Res
14:
742-749,
1997[Web of Science][Medline].
14.
Hoyt, RF, Jr,
DeLeonardis J,
Clevenger R,
and
Wiener SM.
Gallbladder catheterization: a common portal for selectively delivering therapeutic agents to murine hepatobiliary and pancreatic tissues (Abstract).
Contemp Topics Lab Animal Sci
35:
59,
1996.
15.
Koga, A,
and
Todo S.
Morphological and functional changes in the tight junctions of the bile canaliculi induced by bile duct ligation.
Cell Tissue Res
195:
267-276,
1978[Web of Science][Medline].
16.
Ku, Y,
Iwasaki T,
Fukumoto T,
Tominaga M,
Muramatsu S,
Kusunoki N,
Sugimoto T,
Suzuki Y,
Kuroda Y,
Saitoh Y,
Sako M,
Matsumoto S,
Hirota S,
and
Obara H.
Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion.
Ann Surg
227:
519-526,
1998[Web of Science][Medline].
17.
Meijer, DK,
and
Molema G.
Targeting of drugs to the liver.
Semin Liver Dis
15:
202-256,
1995[Web of Science][Medline].
18.
Metz, J,
Aoki A,
Merlo M,
and
Forssmann WG.
Morphological alterations and functional changes of interhepatocellular junctions induced by bile ligation.
Cell Tissue Res
82:
299-310,
1997.
19.
Peeters, MJ,
Patijn GA,
Lieber A,
Meuse L,
and
Kay MA.
Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration.
Hum Gene Ther
7:
1693-1699,
1996[Web of Science][Medline].
20.
Peterson, RE,
and
Fujimoto JM.
Retrograde intrabiliary injection: absorption of water and other compounds from the rat biliary tree.
J Pharmacol Exp Ther
185:
150-162,
1973[Abstract/Free Full Text].
21.
Phillips, MJ,
Oshio C,
Miyairi M,
and
Smith CR.
Intrahepatic cholestasis as a canalicular motility disorder. Evidence using cytochalasin.
Lab Invest
48:
205-211,
1983[Web of Science][Medline].
22.
Powell, DW.
Barrier function of epithelia.
Am J Physiol Gastrointest Liver Physiol
241:
G275-G288,
1981[Abstract/Free Full Text].
23.
Rahner, C,
Stieger B,
and
Landmann L.
Structure-function correlation of tight junctional impairment following intrahepatic and extrahepatic cholestasis in rat liver.
Gastroenterology
110:
1564-1578,
1996[Web of Science][Medline].
24.
Ravikumar, TS,
Pizzorno G,
Bodden W,
Marsh J,
Strair R,
Pollack J,
Hendler R,
Hanna J,
and
D'Andrea E.
Percutaneous hepatic vein isolation and high dose hepatic arterial infusion chemotherapy for unresetable liver tumors.
Clin Oncol (R Coll Radiol)
12:
2723-2736,
1994.
25.
Robenek, HI,
Herwig J,
and
Thermann H.
The morphologic characterizaton of intercellular junctions between normal human liver cells and cells from patients with extrahepatic cholestasis.
Am J Pathol
100:
93-103,
1980[Abstract].
26.
Rojkind, M,
and
Greenwel P.
The extracellular matrix in the liver.
In: The Liver, Biology and Pathobiology (3rd ed.), edited by Arias IM,
Boyer JL,
Fausto N,
Jakoby WB,
Schachter DA,
and Shafritz DA.. New York: Raven, 1994, p. 843-868.
27.
Schweizer, W,
Duda P,
Tanner S,
Balsiger D,
Hoflin F,
Blumgart LH,
and
Zimmerman A.
Experimental atrophy/hypertrophy complex (AHC) of the liver: portal vein, but not bile duct obstruction, is the main driving force for the development of AHC in the rat.
J Hepatol
23:
71-78,
1995[Web of Science][Medline].
28.
Simonetti, RG,
Liverati A,
Angiolini C,
and
Pagliaro L.
Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials.
Ann Oncol
8:
117-136,
1997[Abstract/Free Full Text].
29.
Sullivan, DE,
Dash S,
Du H,
Hiramatsu N,
Aydin F,
Kolls J,
Blanchard J,
Baskin G,
and
Gerber MA.
Liver-directed gene transfer in non-human primates.
Hum Gene Ther
1:
1195-1206,
1997.
30.
Tavolini, N.
The intrahepatic biliary epithelium: an area of growing interest in hepatology.
Semin Liver Dis
7:
280-292,
1987[Web of Science][Medline].
31.
Van den Bogaerde, JB,
and
Jordaan M.
Intraductal administration of albendazole for biliary ascariasis.
Am J Gastroenterol
92:
1531-1533,
1997[Web of Science][Medline].
32.
Venook, AP,
and
Warren RS.
Regional chemotherapy approaches for primary and metastatic liver tumours.
Surg Oncol Clin N Am
5:
411-427,
1996[Medline].
33.
Vickers, SM,
Phillips JO,
Kerby JD,
Bynon JS, Jr,
Thompson JA,
and
Curiel DT.
In vivo gene transfer to the human biliary tract.
Gene Ther
3:
824-828,
1996.
34.
Watanabe, N,
Tsukada N,
Smith CR,
and
Phillips MJ.
Motility of bile canaliculi in the living animal: implications for bile flow.
J Cell Biol
113:
1069-1080,
1991[Abstract/Free Full Text].
35.
Wiener SM, Hoyt RF Jr, DeLeonardis J, Clevenger R, Eckhaus M,
Owens J, Jambou R, Trapnell B, Weaver L, Mech C, Bartner H, Kotin RM,
and Safer B. Organ-selective in vivo gene transfer in mice
(Abstract). Sixth International Parvovirus Workshop,
Montpellier, France, 1995, p. 32.
36.
Wiener, SM,
Hoyt RF, Jr,
DeLeonardis JR,
Clevenger RR,
Eckhaus M,
Owens J,
Kotin RM,
and
Safer B.
Organ-specific vector delivery and gene transfer in vivo (Abstract).
Gastroenterology
110:
A1360,
1996[Web of Science].
37.
Yang, Y,
Raper SE,
Cohn JA,
Engelhardt JF,
and
Wilson JM.
An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer.
Proc Natl Acad Sci USA
90:
4601-4605,
1993[Abstract/Free Full Text].
Am J Physiol Gastrointest Liver Physiol 279(1):G49-G66